Clinical Trials Logo

Clinical Trial Summary

Influenza vaccination is indicated for all adults, but the immunogenicity of vaccination has not been assessed in all situations. We are conducting a prospective unblinded study of influenza vaccine recipients.


Clinical Trial Description

Influenza vaccination is indicated for all adults, but the immunogenicity of vaccination has not been assessed in all situations. In particular, immune responses following influenza vaccination have not been studied in the setting of advanced melanoma and in the context of various anti-tumor treatments. In this study, we will look at the immune response of subjects receiving vaccination. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03315975
Study type Interventional
Source University of Pennsylvania
Contact
Status Active, not recruiting
Phase Phase 4
Start date October 20, 2017
Completion date July 1, 2024

See also
  Status Clinical Trial Phase
Completed NCT01489358 - Chikungunya Virus Vaccine Trial in Healthy Adults Phase 1